Division of Pediatric Cardiology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Pediatr Cardiol. 2024 Oct;45(7):1485-1492. doi: 10.1007/s00246-023-03188-9. Epub 2023 Jul 1.
Balloon aortic valvuloplasty (BAV) is performed in children with significant aortic stenosis (AS). Traditionally, contrast angiography measures the annulus and assesses aortic regurgitation (AR) after each dilation. Echocardiographic guidance is hypothesized to reduce contrast and radiation exposure, without compromising efficacy or safety. Patients < 10 kg undergoing BAV from 2013 to 2022 were retrospectively investigated. Agreement between echocardiographic and angiographic annulus measurements was assessed. Echocardiogram-guided (eBAV) and traditional angiogram-guided (tBAV) outcomes were compared controlling for weight, critical AS, and other congenital heart disease (CHD). Twelve eBAV and 19 tBAV procedures were performed. The median age was 33 days, median weight was 4.3 kg, 7 patients (23%) had critical AS, and 9 patients (29%) had other CHD. Annulus measurements by intraprocedural echocardiography and angiography displayed excellent correlation (ICC 0.95, p < 0.001). eBAV patients received less contrast (0.5 vs 3.5 ml/kg, p < 0.01). Five recent eBAV procedures were performed contrast free. Radiation exposure was not statistically different between the eBAV and tBAV groups (155 vs 313 µGy·M, p = 0.12). One eBAV patient (8%) and 3 tBAV patients (16%, p = 0.62) experienced serious adverse events. Technical success (gradient < 35 mmHg and increase in AR by ≤ 1 grade) occurred in 11 eBAV patients (92%) and 16 tBAV patients (84%, p = 0.22). AR increased in 2 eBAV patients (17%) and 8 tBAV patients (44%, p = 0.02). eBAV was associated with similar efficacy and significantly lower contrast exposure and risk of aortic regurgitation. There was strong agreement between aortic valve annulus measurements by intraprocedural echocardiography and angiography, ultimately permitting contrast free BAV.
球囊主动脉瓣成形术(BAV)用于治疗严重主动脉瓣狭窄(AS)的儿童。传统上,对比血管造影术测量瓣环并在每次扩张后评估主动脉瓣反流(AR)。超声心动图引导被假设为减少造影剂和辐射暴露,同时不影响疗效或安全性。回顾性研究了 2013 年至 2022 年间接受 BAV 的体重<10kg 的患者。评估了超声心动图和血管造影术测量瓣环的一致性。在控制体重、严重 AS 和其他先天性心脏病(CHD)的情况下,比较了超声心动图引导(eBAV)和传统血管造影术引导(tBAV)的结果。共进行了 12 例 eBAV 和 19 例 tBAV 手术。中位年龄为 33 天,中位体重为 4.3kg,7 例(23%)患者为严重 AS,9 例(29%)患者有其他 CHD。术中超声心动图和血管造影术测量的瓣环显示出极好的相关性(ICC 0.95,p<0.001)。eBAV 患者接受的造影剂较少(0.5 与 3.5ml/kg,p<0.01)。最近的 5 例 eBAV 手术均未使用造影剂。eBAV 和 tBAV 组的辐射暴露无统计学差异(155 与 313μGy·M,p=0.12)。1 例 eBAV 患者(8%)和 3 例 tBAV 患者(16%,p=0.62)发生严重不良事件。11 例 eBAV 患者(92%)和 16 例 tBAV 患者(84%,p=0.22)的技术成功率(梯度<35mmHg,AR 增加不超过 1 级)。2 例 eBAV 患者(17%)和 8 例 tBAV 患者(44%,p=0.02)的 AR 增加。eBAV 的疗效相似,但造影剂暴露和主动脉瓣反流的风险显著降低。术中超声心动图和血管造影术测量的主动脉瓣环具有很强的一致性,最终允许无造影剂 BAV。
Heart Lung Circ. 2019-4
JACC Cardiovasc Interv. 2013-9
Cardiovasc Drugs Ther. 2024-12
JACC Cardiovasc Interv. 2021-4-12
Catheter Cardiovasc Interv. 2017-8-1